source
- Pfizer partners with China's Innovent Biologics on $10.5 billion deal for 12 early-stage cancer programsPfizer announced a collaboration with Innovent Biologics of China to develop a suite of cancer therapies. The agreement covers up to 12 early-stage antibody‑drug conjugates and multi‑specific anti…
- White House reviews FDA's new prescription drug user fee agreement for 2028-2032The White House is currently reviewing a recently negotiated agreement between the FDA and the biopharma industry that determines the level of prescription-drug user fees for the period 2028 throug…